MP03-06 PROSPECTIVE STUDY ON FDG-PET/CT FOR ON-TREATMENT ASSESSMENT OF RESPONSE TO NEOADJUVANT OR INDUCTION CHEMOTHERAPY IN INVASIVE BLADDER CANCER. (May 2022)